WeVote
Log In

Bill

Bill

H 4607

An Act relative to increasing access to epinephrine

194th Legislature (2025-2026) Introduced by James Arena-DeRosa and 22 co-sponsors

H 4607 expands Massachusetts epinephrine access through standing orders and public stocking to reduce anaphylaxis deaths, with implementation costs and liability concerns pending committee review.

New draft substituted, see H5443
0
WeVote Research Nonpartisan
Bill Summary · H 4607

Legislative bill overview

H 4607 aims to expand access to epinephrine in Massachusetts by likely removing barriers to obtaining auto-injectors, potentially including provisions for standing orders, pharmacy access, or stocking requirements in public spaces. The bill consolidates or relates to other epinephrine-focused measures (H2367, H2500, H2503) being reviewed simultaneously by the legislature.

Why is this important

Epinephrine auto-injectors are life-saving devices for individuals experiencing severe allergic reactions (anaphylaxis), and access delays can be fatal. Broadening availability—whether through schools, workplaces, public venues, or easier prescribing—can reduce mortality and emergency room visits among vulnerable populations, particularly children.

Potential points of contention

  • Cost and funding: Expanded access requires determining who bears the financial burden—insurers, pharmacies, municipalities, or the state—which could impact healthcare budgets and insurance premiums
  • Liability concerns: Businesses and institutions stocking epinephrine may worry about liability if auto-injectors are used improperly or by unauthorized individuals without clear legal protections
  • Standing order implementation: Allowing pharmacists or non-prescribers to dispense epinephrine without individual prescriptions raises questions about medical oversight, training requirements, and whether public health gains outweigh potential misuse risks

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.